Role of the high mobility group A* proteins in human lipomas

Carcinogenesis

Volumn 22, Issue 10, 2001, Pages 1583-1591

  Fedele, Monica ^a,b   Battista, Sabrina ^a,b   Manfioletti, Guidalberto ^c   Croce, Carlo Maria ^d   Giancotti, Vincenzo ^c   Fusco, Alfredo ^a,e  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c UNIVERSITY OF TRIESTE   (Italy)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

^e Univ degli Studi di Catanzaro   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; DNA; GENE PRODUCT; HIGH MOBILITY GROUP A PROTEIN; HIGH MOBILITY GROUP A1 PROTEIN; HIGH MOBILITY GROUP A2 PROTEIN; HIGH MOBILITY GROUP PROTEIN; RNA; THYMIDINE; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOSE TISSUE; ALTERNATIVE RNA SPLICING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BENIGN TUMOR; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CELL GROWTH; CELL LINE; CELL PROLIFERATION; CHROMATIN STRUCTURE; CHROMOSOME 12Q; CHROMOSOME TRANSLOCATION 12; CONTROLLED STUDY; DNA MODIFICATION; GENE FUNCTION; GENE FUSION; GENE LOCUS; GENE MUTATION; GENE REARRANGEMENT; GENE SEQUENCE; GROWTH RATE; HUMAN; HUMAN CELL; LIPOMA; LIPOMATOSIS; MESENCHYME; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROADIPOCYTE; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN SYNTHESIS; TRANSGENIC MOUSE;

EID: 0034794671     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/22.10.1583     Document Type: Article

References (121)

1. Complete murine cDNA sequence, genomic structure and tissue expression of the high mobility group protein HMG-1 (Y)
2. Alternative processing of mRNAs encoding mammalian chromosomal high-mobility-group proteins HMG-I and HMG-Y
3. cDNA cloning of the HMGI-C phosphoprotein, a nuclear protein associated with neoplastic and undifferentiated phenotypes
4. Expression and cDNA cloning of human HMGI-C phosphoprotein
5. Organization, inducible-expression and chromosome localization of the human HMG-I(Y) non-histone protein gene
6. Isolation and characterization of the gene coding for murine high-mobility-group protein HMGI-C
7. The gene for the human architectural transcription factor HMGI-C consists of five exons each coding for a distinct functional element
8. Insect proteins homologous to mammalian high mobility group proteins I/Y (HMG I/Y). Characterization and binding to linear and four-way junction DNA
9. Genomic structure and expression of the murine Hmgi-c gene
10. High mobility group proteins cHMG1a, cHMG1b and cHMGI are distinctly distributed in chromosomes and differentially expressed during ecdysone dependent cell differentiation
11. Retinoid-dependent recruitment of a histone H1 displacement activity by retinoic acid receptor
12. Specific A. T DNA sequence binding of RP-HPLC purified HMG-I
13. The ATDNA-binding domain of mammalian high mobility group I chromosomal proteins. A novel peptide motif for recognizing DNA structure
14. Short peptide fragments derived from HMG-I/Y proteins bind specifically to the minor groove of DNA
15. Genomic characterization of human HMGIC, a member of the accessory transcription factor family found at translocation breakpoints in lipomas
16. Genomic structure and expression of the murine Hmgi (y) gene
17. Purification and postsynthetic modifications of Friend erythroleukemic cell high mobility group protein HMG-I
18. Differential in vivo modifications of the HMGI (Y) non-histone chromatin proteins modulate nucleosome and DNA interactions
19. Phosphorylation of HMG-I by protein kinase C attenuates its binding affinity to the promoter regions of protein kinase C gamma and neurogranin/RC3 genes
20. Phosphorylation of the DNA-binding domain of non-histone high-mobility group I protein by cdc2 kinase: Reduction of binding affinity
21. Phosphorylation by cdc2 kinase modulates DNA binding activity of high mobility group I nonhistone chromatin protein
22. Mass spectrometric analysis of the HMGY protein from Lewis lung carcinoma. Identification of phosphorylation sites
23. A link between apoptosis and degree of phosphorylation of high mobility group A1a protein in leukaemic cells
24. Acetylation of HMG I (Y) by CBP turns off IFN beta expression by disrupting the enhanceosome
25. Recruitment of CBP/p300 by the IFN beta enhanceosome is required for synergistic activation of transcription
26. Calcium-dependent ADP-ribosylation of high-mobility-group I (HMGI) proteins
27. Developmental genetics. Living with bad architecture
28. Multiple closely-linked NFAT/octamer and HMG I (Y) binding sites are part of the interleukin-4 promoter
29. HMGI (Y) and Sp1 in addition to NF-kappa B regulate transcription of the MGSA/GRO alpha gene
30. Multiple proteins bind the insulin response element in the human IGFBP-1 promoter
31. High mobility group I/Y protein functions as a specific cofactor for Oct-2A: Mapping of interaction domains
32. NF-kappa B mediated transcriptional activation is enhanced by the architectural factor HMGI-C
33. Regulation of cell-type-specific interleukin-2 receptor alpha-chain gene expression: Potential role of physical interactions between Elf-1, HMG-I (Y) and NF-kappa B family proteins
34. Functional interaction between the POU domain protein Tst-1/Oct-6 and the high-mobility-group protein HMG-I/Y
35. The high mobility group protein HMG I (Y) is an essential structural component of a virus-inducible enhancer complex
36. The high mobility group protein HMG I (Y) is required for NF-kappa B-dependent virus induction of the human IFN-beta gene
37. Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome
38. Intra- and intermolecular cooperative binding of high-mobility-group protein I (Y) to the beta-interferon promoter
39. Reversal of intrinsic DNA bends in the IFN beta gene enhancer by transcription factors and the architectural protein HMG I (Y)
40. The mechanism of transcriptional synergy of an in vitro assembled interferon-beta enhanceosome
41. Binding of HMG-I (Y) imparts architectural specificity to a positioned nucleosome on the promoter of the human interleukin-2 receptor alpha gene
42. High-mobility-group chromosomal proteins: Architectural components that facilitate chromatin function
43. Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins
44. In vivo topoisomerase II cleavage of the Drosophila histone and satellite III repeats: DNA sequence and structural characteristics
45. Characterization of SAF-A, a novel nuclear DNA binding protein from HeLa cells with high affinity for nuclear
46. Binding of matrix attachment regions to lamin B1
47. SAR-dependent mobilization of histone H1 by HMG-I/Y in vitro: HMG-I/Y is enriched in H1-depleted chromatin
48. HMG-I (Y) recognizes base-unpairing regions of matrix attachment sequences and its increased expression is directly linked to metastatic breast cancer phenotype
49. Directional binding of HMG-I (Y) on four-way junction DNA and the molecular basis for competitive binding with HMG-1 and histone H1
50. Intranuclear distribution of HMGI/Y proteins. An immunocytochemical study
51. Cdc2 and Cdk2 kinase activated by transforming growth factor-beta 1 trigger apoptosis through the phosphorylation of retinoblastoma protein in FaO hepatoma cells
52. HMGI-C expression patterns in human tissues. Implications for the genesis of frequent mesenchymal tumors
53. HMGI-C, a member of the high mobility group family of proteins, is expressed in hematopoietic stem cells and in leukemic cells
54. In vivo modulation of Hmgic reduces obesity
55. Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C
56. High level expression of the HMGI (Y) gene during embryonic development
57. Elevated levels of a specific class of nuclear phosphoproteins in cells transformed with v-ras and v-mos oncogenes and by cotransfection with c-myc and polyoma middle T genes
58. Changes in nuclear proteins following transformation of rat thyroid epithelial cells by a murine sarcoma retrovirus
59. Analysis of the HMGI nuclear proteins in mouse neoplastic cells induced by different procedures
60. The expression of the high mobility group HMGI (Y) proteins correlates with the malignant phenotype of human thyroid neoplasias
61. Detection of high mobility group I HMGI (Y) protein in the diagnosis of thyroid tumors: HMGI (Y) expression represents a potential diagnostic indicator of carcinoma
62. The expression of the high mobility group I (Y) mRNA in thyroid cancers: Useful tool of differential diagnosis of thyroid nodules
63. Increased expression of high mobility group protein I (Y) in high grade prostate cancer determined by in situ hybridization
64. Expression of high mobility group I (HMGI) proteins in squamous intraepithelial lesions (SILs) of uterine cervix
65. Human colorectal carcinomas express high levels of high mobility group HMGI (Y) proteins
66. Determination of high mobility group I (Y) expression level in colorectal neoplasias: A potential diagnostic marker
67. High mobility group HMGI (Y) protein expression in human colorectal hyperplastic and neoplastic diseases
68. Pancreatic duct cell carcinomas express high levels of high mobility group I (Y) proteins
69. Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells
70. Adenovirus-mediated suppression of HMGI (Y) protein synthesis as potential therapy of human malignant neoplasias
71. HMG-I/Y, a new c-Myc target gene and potential oncogene
72. The oncogenic properties of the HMG-I gene family
73. Neoplastic transformation of rat thyroid cells requires the junB and fra-1 gene induction which is dependent on the HMGI-C gene product
74. A uterine leiomyoma showing both t (12:14) and del (7) abnormalities
75. A specific translocation, t (12;14) (q14-15;q23-24), characterizes a subgroup of uterine leiomyomas
76. Inv (12) (p11.2q13) in an endometrial polyp
77. Cytogenetic studies of adipose tissue tumors. II. Recurrent reciprocal translocation t (12;16) (q13;p11) in myxoid liposarcomas
78. Cytogenetic profile of 109 lipomas
79. A hamartoma of the breast with an aberration of 12q mapped to the MAR region by fluorescence in situ hybridization
80. Correlation between clinicopathological features and karyotype in lipomatous tumors. A report of 178 cases from the Chromosomes and Morphology (CHAMP) Collaborative Study Group
81. Chromosome abnormalities in bilateral breast carcinomas. Cytogenetic evaluation of the clonal origin of multiple primary tumors
82. Cytogenetic aberrations in 188 benign and borderline adipose tissue tumors
83. A specific translocation, t (12;14) (q14-15;q23-24), characterizes a subgroup of uterine leiomyomas
84. Endometrial polyp: Another benign tumor characterized by 12q13-q15 changes
85. Four cytogenetic subgroups can be identified in endometrial polyps
86. Cytogenetics and molecular genetics of bone and soft tissue tumors
87. Aberrations of chromosome segment 12q13-15 characterize a subgroup of hemangiopericytomas
88. Regional fine mapping of the multiple-aberration region involved in uterine leiomyoma, lipoma and pleomorphic adenoma of the salivary gland to 12q15
89. Cytogenic and molecular analysis of an aggressive angiomyxoma
90. Identification of the chromosome 12 translocation breakpoint region of a pleomorphic salivary gland adenoma with t (1;12) (p22;q15) as the sole cytogenetic abnormality
91. Physical mapping of chromosome 12q breakpoints in lipoma, pleomorphic salivary gland adenoma, uterine leiomyoma and myxoid liposarcoma
92. Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours
93. Description of a novel fusion transcript between HMGI-C, a gene encoding for a member of the high mobility group proteins and the mitochondrial aldehyde dehydrogenase gene
94. Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains
95. Intron 3 of HMGIC is the most frequent target of chromosomal aberrations in human tumors and has been conserved basically for at least 30 million years
96. Molecular characterization of 12q14-15 rearrangements in three pulmonary chondroid hamartomas
97. Amplification of a rearranged form of the high-mobility group protein gene HMGI-C in OsA-CI osteosarcoma cells
98. LPP, the preferred fusion partner gene of HMGIC in lipomas, is a novel member of the LIM protein gene family
99. Expression of reciprocal fusion transcripts of the HMGIC and LPP genes in parosteal lipoma
100. Novel cysteine-rich motif and homeodomain in the product of the Caenorhabditis elegans cell lineage gene lin-11
101. The LIM protein RBTN2 and the basic helix-loop-helix protein TAL1 are present in a complex in erythroid cells
102. Apterous, a gene required for imaginal disc development in Drosophila encodes a member of the LIM family of developmental regulatory proteins
103. Synergistic activation of the insulin gene by a LIM-homeo domain protein and a basic helix-loop-helix protein: Building a functional insulin minienhancer complex
104. Cysteine-rich LIM domains of LIM-homeodomain and LIM-only proteins contain zinc but not iron
105. The t (3;12) (q27;q14-q15) with underlying HMGIC-LPP fusion is not determining an adipocytic phenotype
106. LHFP, a novel translocation partner gene of HMGIC in a lipoma, is a member of a new family of LHFP-like genes
107. Transcriptional activation of HMGI-C in three pulmonary hamartomas each with a der (14)t (12;14) as the sole cytogenetic abnormality
108. Duplication of chromosome segment 12q15-24 is associated with atypical lipomatous tumors: A report of the CHAMP collaborative study group. Chromosomes and Morphology
109. Expression of HMGI-C and HMGI (Y) in ordinary lipoma and atypical lipomatous tumors: Immunohistochemical reactivity correlates with karyotypic alterations
110. Coordinated expression and amplification of the MDM2, CDK4 and HMGI-C genes in atypical lipomatous tumours
111. Truncated and chimeric HMGI-C genes induce neoplastic transformation of NIH3T3 murine fibroblasts
112. The expression of a truncated HMGI-C gene induces gigantism associated with lipomatosis
113. Transgenic mice expressing a truncated form of the high mobility group I-C protein develop adiposity and an abnormally high prevalence of lipomas
114. Clonal rearrangement of chromosome band 6p21 in the mesenchymal component of pulmonary chondroid hamartoma
115. HMGIY is the target of 6p21.3 rearrangements in various benign mesenchymal tumors
116. HMGI (Y) activation by chromosome 6p21 rearrangements in multilineage mesenchymal cells from pulmonary hamartoma
117. HMGI (Y) expression in human uterine leiomyomata. Involvement of another high-mobility group architectural factor in a benign neoplasm
118. Misexpression of disrupted HMGI architectural factors activates alternative pathways of tumorigenesis
119. Induction of fatty acid synthetase synthesis in differentiating 3T3-L1 preadipocytes
120. Critical role of the HMGI (Y) proteins in adipocytic cell growth and differentiation
121. Overexpression of proteins HMGA1 induces cell cycles deregulation and apoptosis in normal rat thyroid cells